Publikationen von 0000-0002-6654-1665
(ORCID: 0000-0002-6654-1665)

Rosenow, F., Schade-Brittinger, C., Burchardi, N., Arnold, Stephan, LaLiMo Study Group, , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference (2012) The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study. Journal of Neurology, Neurosurgery and Psychiatry 83, S. 1093-1098.